As part of its ongoing efforts to protect patient access to evidence-based therapies, NANS has submitted a formal comment letter to Cigna regarding Medical Coverage Policy 0539, which currently classifies Peripheral Nerve Stimulation (PNS) as “not medically necessary.”
In the letter, NANS highlights that contemporary PNS systems are FDA-cleared and supported by randomized and prospective clinical data demonstrating meaningful improvements in pain and function with a favorable safety profile.
The Society believes the current non-coverage designation does not reflect the maturity of the evidence or PNS’s role in modern pain management.
NANS has respectfully urged Cigna to revise the policy and remains committed to continued engagement to ensure coverage aligns with current clinical standards.